Last Updated: February 1 2023

Resveratrol is a molecule found in wine that is believed to be effective at protecting the heart. It seems to improve blood flow and may be an insulin sensitizer. It may hypothetically increase lifespan, but the evidence that it does so in mammals is limited.

Resveratrol is most often used for

What is resveratrol?

Resveratrol is a compound present in grapes. It is most well-known for its presence in red wine. The popularity of this compound is attributed to a phenomenon called the “French Paradox”, which refers to the low incidence of cardiovascular disease among the French population despite their high intake of dietary fat. This low incidence was thought to be attributed to their intake of red wine.[1]

What are resveratrol’s main benefits?

While resveratrol is best known for its potential cardiovascular benefits, the compound has been the subject of multiple studies focused on its other potential benefits.

Resveratrol is thought to be beneficial for atherosclerosis prevention based on promising results from in vitro studies regarding potential molecular targets of resveratrol in atherosclerotic arteries and on the effects of resveratrol on low-density lipoproteins (LDL).[2][3][4] In rodent studies, resveratrol displayed modest enhancements for vasorelaxation and blood flow[5][6] and provided benefits in rodent models of type 2 diabetes.[7]

Resveratrol improves glycemic control in people with type 2 diabetes,[8][9] but it may not effectively increase insulin sensitivity in people without diabetes.[10]

Based on in vivo studies evaluating potential fat loss benefits from resveratrol, the compound may cause some fat loss, although this is most likely an insignificant effect. The benefits are modest and overall have no effect on fat loss over the short term.[11]

What are resveratrol’s main drawbacks?

Human studies suggest resveratrol can be supplemented at dosages up to 5 grams daily with little to no side effects outside of some intestinal upset and nausea, which are likely due to resveratrol’s poor bioavailability.[12][13]

How does resveratrol work?

Several mechanisms are proposed as to how resveratrol may exert its cardioprotective effects. Resveratrol may inhibit pro-hypertrophic signaling molecules, improve myocardial calcium handling, and reduce oxidative stress and inflammation.[14]

What else is Resveratrol known as?
Note that Resveratrol is also known as:
  • Red Wine Extract
  • 3 5 4'-trihydroxystilbene
Dosage information

The lower end of supplementation tends to be for cardiovascular health, insulin sensitivity, and longevity for somebody who is otherwise unhealthy is 5-10mg daily. For persons who are otherwise healthy, dosages between the range of 150-445mg have been used (with no clear indication for what is the optimal dose).

Supplementing for cerebral blood flow requires a dose in the 250-500mg range whereas supplementation for aromatase inhibition requires 500mg as well.

Supplementation of resveratrol refers to trans-resveratrol exclusively.

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Resveratrol
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Research Breakdown

1.^Lippi G, Franchini M, Favaloro EJ, Targher GModerate red wine consumption and cardiovascular disease risk: beyond the "French paradox".Semin Thromb Hemost.(2010-Feb)
2.^Kao CL, Chen LK, Chang YL, Yung MC, Hsu CC, Chen YC, Lo WL, Chen SJ, Ku HH, Hwang SJResveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation.J Atheroscler Thromb.(2010-Sep-30)
3.^Zou J, Huang Y, Chen Q, Wei E, Cao K, Wu JMEffects of resveratrol on oxidative modification of human low density lipoprotein.Chin Med J (Engl).(2000-Feb)
8.^Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B, Wittmann IResveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patientsBr J Nutr.(2011 Aug)
9.^Hoseini A, Namazi G, Farrokhian A, Reiner Ž, Aghadavod E, Bahmani F, Asemi ZThe effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease.Food Funct.(2019-Sep-01)
10.^Marlies de Ligt, Maaike Bergman, Rodrigo Mancilla Fuentes, Hans Essers, Esther Moonen-Kornips, Bas Havekes, Vera B Schrauwen-Hinderling, Patrick SchrauwenNo effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trialAm J Clin Nutr.(2020 Jun 3)
11.^Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen PCalorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humansCell Metab.(2011 Nov 2)
12.^Ketan R Patel, Edwina Scott, Victoria A Brown, Andreas J Gescher, William P Steward, Karen BrownClinical trials of resveratrolAnn N Y Acad Sci.(2011 Jan)
13.^Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJPhase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.Cancer Prev Res (Phila).(2011-Sep)
14.^Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad JResveratrol: A Double-Edged Sword in Health Benefits.Biomedicines.(2018-Sep-09)
15.^Constant JAlcohol, ischemic heart disease, and the French paradoxCoron Artery Dis.(1997 Oct)
16.^Lippi G, Franchini M, Favaloro EJ, Targher GModerate red wine consumption and cardiovascular disease risk: beyond the "French paradox"Semin Thromb Hemost.(2010 Feb)
17.^Mezzano D, Leighton F, Strobel P, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Rozowski J, Pereira JMediterranean diet, but not red wine, is associated with beneficial changes in primary haemostasisEur J Clin Nutr.(2003 Mar)
18.^Mezzano D, Leighton F, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Pérez DD, Mizón C, Rozowski J, San Martín A, Pereira JComplementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factorsEur J Clin Nutr.(2001 Jun)
19.^Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM, Berenguer T, Jakszyn P, Martínez C, Sánchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quirós JR, Amiano P, Dorronsoro M, Larrañaga N, Barricarte A, Ardanaz E, González CAConcentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohortBr J Nutr.(2008 Jul)
20.^Delmas D, Lançon A, Colin D, Jannin B, Latruffe NResveratrol as a chemopreventive agent: a promising molecule for fighting cancerCurr Drug Targets.(2006 Apr)
22.^Liang Z, Yang Y, Cheng L, Zhong GYCharacterization of polyphenolic metabolites in the seeds of Vitis germplasmJ Agric Food Chem.(2012 Feb 8)
26.^Diaz LE, Munoz DR, Prieto RE, Cuervo SA, Gonzalez DL, Guzman JD, Bhakta SAntioxidant, Antitubercular and Cytotoxic Activities of Piper imperialeMolecules.(2012 Apr 5)
27.^Poulose SM, Fisher DR, Larson J, Bielinski DF, Rimando AM, Carey AN, Schauss AG, Shukitt-Hale BAnthocyanin-rich açai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cellsJ Agric Food Chem.(2012 Feb 1)
28.^Sobolev VS, Cole RJtrans-resveratrol content in commercial peanuts and peanut productsJ Agric Food Chem.(1999 Apr)
29.^Rius C, Abu-Taha M, Hermenegildo C, Piqueras L, Cerda-Nicolas JM, Issekutz AC, Estañ L, Cortijo J, Morcillo EJ, Orallo F, Sanz MJTrans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulationJ Immunol.(2010 Sep 15)
30.^Anisimova NY, Kiselevsky MV, Sosnov AV, Sadovnikov SV, Stankov IN, Gakh AATrans-, cis-, and dihydro-resveratrol: a comparative studyChem Cent J.(2011 Dec 20)
32.^Leiro J, Alvarez E, Arranz JA, Laguna R, Uriarte E, Orallo FEffects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genesJ Leukoc Biol.(2004 Jun)
33.^Fabbrocini G, Staibano S, De Rosa G, Battimiello V, Fardella N, Ilardi G, La Rotonda MI, Longobardi A, Mazzella M, Siano M, Pastore F, De Vita V, Vecchione ML, Ayala FResveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot studyAm J Clin Dermatol.(2011 Apr 1)
36.^Rahman S, Islam RMammalian Sirt1: insights on its biological functionsCell Commun Signal.(2011 May 8)
37.^Milner JCellular regulation of SIRT1Curr Pharm Des.(2009)
38.^Verdin E, Hirschey MD, Finley LW, Haigis MCSirtuin regulation of mitochondria: energy production, apoptosis, and signalingTrends Biochem Sci.(2010 Dec)
39.^Li X, Kazgan NMammalian sirtuins and energy metabolismInt J Biol Sci.(2011)
40.^White AT, Schenk SNAD+/NADH and skeletal muscle mitochondrial adaptations to exerciseAm J Physiol Endocrinol Metab.(2012 Mar 27)
43.^Agarwal B, Baur JAResveratrol and life extensionAnn N Y Acad Sci.(2011 Jan)
44.^Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DASmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature.(2003 Sep 11)
45.^Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BKSubstrate-specific activation of sirtuins by resveratrolJ Biol Chem.(2005 Apr 29)
46.^Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn KSRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1J Biol Chem.(2010 Mar 12)
47.^Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang MResveratrol is not a direct activator of SIRT1 enzyme activityChem Biol Drug Des.(2009 Dec)
49.^Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, Towler MC, Brown LJ, Ogunbayo OA, Evans AM, Hardie DGUse of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activationCell Metab.(2010 Jun 9)
51.^Park CE, Kim MJ, Lee JH, Min BI, Bae H, Choe W, Kim SS, Ha JResveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinaseExp Mol Med.(2007 Apr 30)
53.^Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx JAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature.(2009 Apr 23)
54.^Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DASIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial functionCell Metab.(2012 May 2)
56.^Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, Cohen RA, Zang MSIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinaseJ Biol Chem.(2008 Jul 18)
57.^Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JHResveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterasesCell.(2012 Feb 3)
58.^Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ, Auwerx JSpecific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidationCell Metab.(2008 Nov)
60.^Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver PMetabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alphaEMBO J.(2007 Apr 4)
61.^Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver PNutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1Nature.(2005 Mar 3)
62.^Jäger S, Handschin C, St-Pierre J, Spiegelman BMAMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alphaProc Natl Acad Sci U S A.(2007 Jul 17)
64.^Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UKHigh absorption but very low bioavailability of oral resveratrol in humansDrug Metab Dispos.(2004 Dec)
65.^Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JLResveratrol bioavailability and toxicity in humansMol Nutr Food Res.(2010 Jan)
66.^Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJPhase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamicsCancer Prev Res (Phila).(2011 Sep)
67.^Almeida L, Vaz-da-Silva M, Falcão A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, Soares-da-Silva PPharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteersMol Nutr Food Res.(2009 May)
71.^Vaz-da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-da-Silva PEffect of food on the pharmacokinetic profile of trans-resveratrolInt J Clin Pharmacol Ther.(2008 Nov)
73.^De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GMSulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenumXenobiotica.(2000 Jun)
76.^Smoliga JM, Baur JA, Hausenblas HAResveratrol and health--a comprehensive review of human clinical trialsMol Nutr Food Res.(2011 Aug)
77.^De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GMSulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoidsXenobiotica.(2000 Sep)
79.^Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DEPhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentCancer Epidemiol Biomarkers Prev.(2007 Jun)
82.^Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DERepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisCancer Res.(2010 Nov 15)
84.^Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, Ghiselli A, Momi S, Violi FResveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide productionJ Nutr.(2008 Sep)
86.^Wenzel E, Somoza VMetabolism and bioavailability of trans-resveratrolMol Nutr Food Res.(2005 May)
90.^Jannin B, Menzel M, Berlot JP, Delmas D, Lançon A, Latruffe NTransport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptakeBiochem Pharmacol.(2004 Sep 15)
91.^Belguendouz L, Frémont L, Gozzelino MTInteraction of transresveratrol with plasma lipoproteinsBiochem Pharmacol.(1998 Mar 15)
92.^Curry S, Brick P, Franks NPFatty acid binding to human serum albumin: new insights from crystallographic studiesBiochim Biophys Acta.(1999 Nov 23)
93.^Lançon A, Delmas D, Osman H, Thénot JP, Jannin B, Latruffe NHuman hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated processBiochem Biophys Res Commun.(2004 Apr 16)
94.^Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AYResveratrol protects against global cerebral ischemic injury in gerbilsBrain Res.(2002 Dec 27)
95.^Bertelli A, Bertelli AA, Gozzini A, Giovannini LPlasma and tissue resveratrol concentrations and pharmacological activityDrugs Exp Clin Res.(1998)
96.^Vitrac X, Desmoulière A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Mérillon JMDistribution of (14C)-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administrationLife Sci.(2003 Apr 4)
97.^Camont L, Collin F, Couturier M, Thérond P, Jore D, Gardès-Albert M, Bonnefont-Rousselot DRadical-induced oxidation of trans-resveratrolBiochimie.(2012 Mar)
98.^Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge LEffects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegansMech Ageing Dev.(2007 Oct)
99.^Wang C, Wheeler CT, Alberico T, Sun X, Seeberger J, Laslo M, Spangler E, Kern B, de Cabo R, Zou SThe effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogasterAge (Dordr).(2011 Nov 16)
100.^Bauer JH, Chang C, Morris SN, Hozier S, Andersen S, Waitzman JS, Helfand SLExpression of dominant-negative Dmp53 in the adult fly brain inhibits insulin signalingProc Natl Acad Sci U S A.(2007 Aug 14)
101.^Bauer JH, Morris SN, Chang C, Flatt T, Wood JG, Helfand SLdSir2 and Dmp53 interact to mediate aspects of CR-dependent lifespan extension in D. melanogasterAging (Albany NY).(2009 Jan)
102.^Antosh M, Whitaker R, Kroll A, Hosier S, Chang C, Bauer J, Cooper L, Neretti N, Helfand SLComparative transcriptional pathway bioinformatic analysis of dietary restriction, Sir2, p53 and resveratrol life span extension in DrosophilaCell Cycle.(2011 Mar 15)
105.^Frankel S, Ziafazeli T, Rogina BdSir2 and longevity in DrosophilaExp Gerontol.(2011 May)
106.^Labbé A, Garand C, Cogger VC, Paquet ER, Desbiens M, Le Couteur DG, Lebel MResveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndromeJ Gerontol A Biol Sci Med Sci.(2011 Mar)
107.^Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong RRapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous miceJ Gerontol A Biol Sci Med Sci.(2011 Feb)
108.^Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo RResveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life spanCell Metab.(2008 Aug)
109.^Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TAA low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in micePLoS One.(2008 Jun 4)
110.^Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DAResveratrol improves health and survival of mice on a high-calorie dietNature.(2006 Nov 16)
114.^Li M, Wang QS, Chen Y, Wang ZM, Liu Z, Guo SMResveratrol inhibits neuronal discharges in rat hippocampal CA1 areaSheng Li Xue Bao.(2005 Jun 25)
115.^Gozlan H, Ben-Ari YNMDA receptor redox sites: are they targets for selective neuronal protectionTrends Pharmacol Sci.(1995 Nov)
117.^Zhang LP, Yin JX, Liu Z, Zhang Y, Wang QS, Zhao JEffect of resveratrol on L-type calcium current in rat ventricular myocytesActa Pharmacol Sin.(2006 Feb)
118.^Moldzio R, Radad K, Krewenka C, Kranner B, Duvigneau JC, Rausch WDProtective effects of resveratrol on glutamate-induced damages in murine brain culturesJ Neural Transm.(2013 Mar 5)
123.^Wang Q, Yu S, Simonyi A, Rottinghaus G, Sun GY, Sun AYResveratrol protects against neurotoxicity induced by kainic acidNeurochem Res.(2004 Nov)
124.^Gupta YK, Briyal S, Chaudhary GProtective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in ratsPharmacol Biochem Behav.(2002 Jan-Feb)
126.^Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang LProtective effect of resveratrol against kainate-induced temporal lobe epilepsy in ratsNeurochem Res.(2009 Aug)
127.^Friedman LK, Goldstein B, Rafiuddin A, Roblejo P, Friedman SLack of resveratrol neuroprotection in developing rats treated with kainic acidNeuroscience.(2013 Jan 29)
131.^Tsai RY, Chou KY, Shen CH, Chien CC, Tsai WY, Huang YN, Tao PL, Lin YS, Wong CSResveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant ratsAnesth Analg.(2012 Oct)
133.^Magistretti PJNeuron-glia metabolic coupling and plasticityJ Exp Biol.(2006 Jun)
134.^Araque AAstrocytes process synaptic informationNeuron Glia Biol.(2008 Feb)
135.^Araque A, Carmignoto G, Haydon PGDynamic signaling between astrocytes and neuronsAnnu Rev Physiol.(2001)
136.^Araque A, Parpura V, Sanzgiri RP, Haydon PGTripartite synapses: glia, the unacknowledged partnerTrends Neurosci.(1999 May)
138.^Matés JM, Pérez-Gómez C, Núñez de Castro I, Asenjo M, Márquez JGlutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/deathInt J Biochem Cell Biol.(2002 May)
140.^Quincozes-Santos A, Gottfried CResveratrol modulates astroglial functions: neuroprotective hypothesisAnn N Y Acad Sci.(2011 Jan)
141.^dos Santos AQ, Nardin P, Funchal C, de Almeida LM, Jacques-Silva MC, Wofchuk ST, Gonçalves CA, Gottfried CResveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cellsArch Biochem Biophys.(2006 Sep 15)
142.^de Almeida LM, Piñeiro CC, Leite MC, Brolese G, Tramontina F, Feoli AM, Gottfried C, Gonçalves CAResveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte culturesCell Mol Neurobiol.(2007 Aug)
143.^Bobermin LD, Quincozes-Santos A, Guerra MC, Leite MC, Souza DO, Gonçalves CA, Gottfried CResveratrol prevents ammonia toxicity in astroglial cellsPLoS One.(2012)
144.^Felipo V, Butterworth RFNeurobiology of ammoniaProg Neurobiol.(2002 Jul)
145.^Leite MC, Brolese G, de Almeida LM, Piñero CC, Gottfried C, Gonçalves CAAmmonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine additionBrain Res Bull.(2006 Jun 30)
146.^Lemberg A, Fernández MAHepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stressAnn Hepatol.(2009 Apr-Jun)
149.^Porquet D, Casadesús G, Bayod S, Vicente A, Canudas AM, Vilaplana J, Pelegrí C, Sanfeliu C, Camins A, Pallàs M, Del Valle JDietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8Age (Dordr).(2012 Nov 7)
150.^Kao CL, Chen LK, Chang YL, Yung MC, Hsu CC, Chen YC, Lo WL, Chen SJ, Ku HH, Hwang SJResveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activationJ Atheroscler Thromb.(2010 Sep 30)
151.^Zou J, Huang Y, Chen Q, Wei E, Cao K, Wu JMEffects of resveratrol on oxidative modification of human low density lipoproteinChin Med J (Engl).(2000 Feb)
152.^Zou JG, Huang YZ, Chen Q, Wei EH, Hsieh TC, Wu JMResveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoproteinBiochem Mol Biol Int.(1999 Jun)
153.^Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann UResveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthaseCirculation.(2002 Sep 24)
154.^Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann UEstrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involvedHypertension.(1998 Feb)
155.^Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs JEndothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetesDiabetes.(2007 Mar)
157.^Förstermann U, Münzel TEndothelial nitric oxide synthase in vascular disease: from marvel to menaceCirculation.(2006 Apr 4)
158.^Li H, Witte K, August M, Brausch I, Gödtel-Armbrust U, Habermeier A, Closs EI, Oelze M, Münzel T, Förstermann UReversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive ratsJ Am Coll Cardiol.(2006 Jun 20)
160.^Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Münzel T, Förstermann U, Li HResveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout miceJ Pharmacol Exp Ther.(2010 Oct)
161.^Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi XResveratrol scavenges reactive oxygen species and effects radical-induced cellular responsesBiochem Biophys Res Commun.(2003 Oct 3)
162.^Orallo F, Alvarez E, Camiña M, Leiro JM, Gómez E, Fernández PThe possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumptionMol Pharmacol.(2002 Feb)
167.^Mizutani K, Ikeda K, Kawai Y, Yamori YResveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive ratsJ Nutr Sci Vitaminol (Tokyo).(2000 Apr)
168.^Wang Z, Chen Y, Labinskyy N, Hsieh TC, Ungvari Z, Wu JMRegulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extractsBiochem Biophys Res Commun.(2006 Jul 21)
171.^Wang Z, Hsieh TC, Zhang Z, Ma Y, Wu JMIdentification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatographyBiochem Biophys Res Commun.(2004 Oct 22)
172.^Buryanovskyy L, Fu Y, Boyd M, Ma Y, Hsieh TC, Wu JM, Zhang ZCrystal structure of quinone reductase 2 in complex with resveratrolBiochemistry.(2004 Sep 14)
173.^de Gaetano G, De Curtis A, di Castelnuovo A, Donati MB, Iacoviello L, Rotondo SAntithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumptionAnn N Y Acad Sci.(2002 May)
174.^Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen PCalorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humansCell Metab.(2011 Nov 2)
175.^Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B, Wittmann IResveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patientsBr J Nutr.(2011 Aug)
177.^Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DKModified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatmentNutr Res.(2011 Nov)
179.^Zhang J, Chen L, Zheng J, Zeng T, Li H, Xiao H, Deng X, Hu XThe protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat dietDiabetes Res Clin Pract.(2012 Apr 10)
184.^Umek RM, Friedman AD, McKnight SLCCAAT-enhancer binding protein: a component of a differentiation switchScience.(1991 Jan 18)
185.^Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CAResveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytesPhytother Res.(2008 Oct)
188.^Baile CA, Yang JY, Rayalam S, Hartzell DL, Lai CY, Andersen C, Della-Fera MAEffect of resveratrol on fat mobilizationAnn N Y Acad Sci.(2011 Jan)
189.^Fischer-Posovszky P, Kukulus V, Tews D, Unterkircher T, Debatin KM, Fulda S, Wabitsch MResveratrol regulates human adipocyte number and function in a Sirt1-dependent mannerAm J Clin Nutr.(2010 Jul)
193.^Dolinsky VW, Jones KE, Sidhu RS, Haykowsky M, Czubryt MP, Gordon T, Dyck JRImprovements in Skeletal Muscle Strength and Cardiac Function Induced by Resveratrol Contribute to Enhanced Exercise Performance in RatsJ Physiol.(2012 Apr 2)
194.^Tomasello B, Grasso S, Malfa G, Stella S, Favetta M, Renis MDouble-Face Activity of Resveratrol in Voluntary Runners: Assessment of DNA Damage by Comet AssayJ Med Food.(2012 Mar 22)
196.^Liu M, Liu FResveratrol inhibits mTOR signaling by targeting DEPTORCommun Integr Biol.(2011 Jul)
197.^Liu M, Wilk SA, Wang A, Zhou L, Wang RH, Ogawa W, Deng C, Dong LQ, Liu FResveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTORJ Biol Chem.(2010 Nov 19)
198.^Rajapakse AG, Yepuri G, Carvas JM, Stein S, Matter CM, Scerri I, Ruffieux J, Montani JP, Ming XF, Yang ZHyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrolPLoS One.(2011 Apr 22)
199.^Ghosh HS, McBurney M, Robbins PDSIRT1 negatively regulates the mammalian target of rapamycinPLoS One.(2010 Feb 15)
200.^Schreiner CE, Kumerz M, Gesslbauer J, Schachner D, Joa H, Erker T, Atanasov AG, Heiss EH, Dirsch VMResveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent mannerCardiovasc Res.(2011 Apr 1)
202.^Drummond MJ, Fry CS, Glynn EL, Dreyer HC, Dhanani S, Timmerman KL, Volpi E, Rasmussen BBRapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesisJ Physiol.(2009 Apr 1)
204.^Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP, Sebedio JL, Pujos-Guillot E, Falempin M, Simon C, Coxam V, Andrianjafiniony T, Gauquelin-Koch G, Picquet F, Blanc SResveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the ratFASEB J.(2011 Oct)
207.^Lasse Gliemann, Jakob Friis Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard, Ylva HellstenResveratrol blunts the positive effects of exercise training on cardiovascular health in aged menJ Physiol.(2013 Oct 15)
209.^Gliemann L, Schmidt J, Olesen J, Biensø RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H, Hellsten YReply from Lasse Gliemann, Jakob Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva HellstenJ Physiol.(2013 Oct 15)
211.^Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx JResveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alphaCell.(2006 Dec 15)
212.^Scribbans TD1, Ma JK, Edgett BA, Vorobej KA, Mitchell AS, Zelt JG, Simpson CA, Quadrilatero J, Gurd BJResveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high-intensity interval training in humansAppl Physiol Nutr Metab.(2014 Nov)
213.^Gomez-Cabrera MC1, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo FV, Sastre J, Viña JOral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performanceAm J Clin Nutr.(2008 Jan)
214.^Paulsen G1, Cumming KT, Holden G, Hallén J, Rønnestad BR, Sveen O, Skaug A, Paur I, Bastani NE, Østgaard HN, Buer C, Midttun M, Freuchen F, Wiig H, Ulseth ET, Garthe I, Blomhoff R, Benestad HB, Raastad TVitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trialJ Physiol.(2014 Apr 15)
215.^Bäckesjö CM, Li Y, Lindgren U, Haldosén LAActivation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cellsCells Tissues Organs.(2009)
218.^Morita Y, Wada-Hiraike O, Yano T, Shirane A, Hirano M, Hiraike H, Koyama S, Oishi H, Yoshino O, Miyamoto Y, Sone K, Oda K, Nakagawa S, Tsutsui K, Taketani YResveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovaryReprod Biol Endocrinol.(2012 Feb 23)
220.^Wang Y, Lee KW, Chan FL, Chen S, Leung LKThe red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cellsToxicol Sci.(2006 Jul)
222.^Canistro D, Bonamassa B, Pozzetti L, Sapone A, Abdel-Rahman SZ, Biagi GL, Paolini MAlteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 miceFood Chem Toxicol.(2009 Feb)
223.^Delmas D, Jannin B, Cherkaoui Malki M, Latruffe NInhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell linesOncol Rep.(2000 Jul-Aug)
224.^Sun ZJ, Pan CE, Liu HS, Wang GJAnti-hepatoma activity of resveratrol in vitroWorld J Gastroenterol.(2002 Feb)
226.^Leone S, Cornetta T, Basso E, Cozzi RResveratrol induces DNA double-strand breaks through human topoisomerase II interactionCancer Lett.(2010 Sep 28)
227.^De Salvia R, Festa F, Ricordy R, Perticone P, Cozzi RResveratrol affects in a different way primary versus fixed DNA damage induced by H(2)O(2) in mammalian cells in vitroToxicol Lett.(2002 Sep 5)
228.^Fukuhara K, Miyata NResveratrol as a new type of DNA-cleaving agentBioorg Med Chem Lett.(1998 Nov 17)
230.^Delmas D, Rébé C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N, Solary EResveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cellsJ Biol Chem.(2003 Oct 17)
231.^Pervaiz SResveratrol--from the bottle to the bedsideLeuk Lymphoma.(2001 Feb)
232.^Wenzel E, Soldo T, Erbersdobler H, Somoza VBioactivity and metabolism of trans-resveratrol orally administered to Wistar ratsMol Nutr Food Res.(2005 May)
234.^Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SCDisparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapesJ Nutr.(2002 Jul)
236.^Kucharczak J, Simmons MJ, Fan Y, Gélinas CTo be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosisOncogene.(2003 Dec 8)
238.^Benitez DA, Hermoso MA, Pozo-Guisado E, Fernández-Salguero PM, Castellón EARegulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cellsProstate.(2009 Jul 1)
240.^Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF, Xie LPResveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivoCancer Sci.(2010 Feb)
242.^Hope C, Planutis K, Planutiene M, Moyer MP, Johal KS, Woo J, Santoso C, Hanson JA, Holcombe RFLow concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer preventionMol Nutr Food Res.(2008 Jun)
247.^Kleinedler JJ, Foley JD, Alexander JS, Roerig SC, Hebert VY, Dugas TRSynergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devicesJ Biomed Mater Res B Appl Biomater.(2011 Nov)
248.^Yang JY, Della-Fera MA, Rayalam S, Ambati S, Hartzell DL, Park HJ, Baile CAEnhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetinLife Sci.(2008 May 7)
249.^Park HJ, Yang JY, Ambati S, Della-Fera MA, Hausman DB, Rayalam S, Baile CACombined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytesJ Med Food.(2008 Dec)
250.^Rayalam S, Della-Fera MA, Baile CASynergism between resveratrol and other phytochemicals: implications for obesity and osteoporosisMol Nutr Food Res.(2011 Aug)
252.^Bruckbauer A, Zemel MB, Thorpe T, Akula MR, Stuckey AC, Osborne D, Martin EB, Kennel S, Wall JSSynergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and miceNutr Metab (Lond).(2012 Aug 22)
253.^Raj MH, Abd Elmageed ZY, Zhou J, Gaur RL, Nguyen L, Azam GA, Braley P, Rao PN, Fathi IM, Ouhtit ASynergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cellsGynecol Oncol.(2008 Sep)
254.^Trusov NV, Guseva GV, Aksenov IV, Avren'eva LI, Kravchenko LV, Tutelyan VAEffects of combined treatment with resveratrol and indole-3-carbinolBull Exp Biol Med.(2010 Aug)
257.^Heerdt AS, Young CW, Borgen PICalcium glucarate as a chemopreventive agent in breast cancerIsr J Med Sci.(1995 Feb-Mar)
258.^Olas B, Saluk-Juszczak J, Wachowicz BD-glucaro 1,4-lactone and resveratrol as antioxidants in blood plateletsCell Biol Toxicol.(2008 Apr)
259.^Kowalczyk MC, Kowalczyk P, Tolstykh O, Hanausek M, Walaszek Z, Slaga TJSynergistic effects of combined phytochemicals and skin cancer prevention in SENCAR miceCancer Prev Res (Phila).(2010 Feb)
260.^Vetvicka V, Volny T, Saraswat-Ohri S, Vashishta A, Vancikova Z, Vetvickova JGlucan and resveratrol complex--possible synergistic effects on immune systemBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub.(2007 Jun)
261.^Cristòfol R, Porquet D, Corpas R, Coto-Montes A, Serret J, Camins A, Pallàs M, Sanfeliu CNeurons from senescence-accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrolJ Pineal Res.(2012 Apr)
263.^Kisková T, Ekmekcioglu C, Garajová M, Orendáš P, Bojková B, Bobrov N, Jäger W, Kassayová M, Thalhammer TA combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesisEur J Cancer Prev.(2012 Mar)
264.^Radhakrishnan S, Reddivari L, Sclafani R, Das UN, Vanamala JResveratrol potentiates grape seed extract induced human colon cancer cell apoptosisFront Biosci (Elite Ed).(2011 Jun 1)
266.^Edwards JA, Beck M, Riegger C, Bausch JSafety of resveratrol with examples for high purity, trans-resveratrol, resVida(®)Ann N Y Acad Sci.(2011 Jan)
267.^Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M, McCormick DLSubchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activityFood Chem Toxicol.(2011 Dec)
268.^Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown KClinical trials of resveratrolAnn N Y Acad Sci.(2011 Jan)